It all kind of started with the promotion of pediatric bipolar to sell this stuff for children.
Its scary how these people operate.
As noted, many other states succeeded in forcing J&J to pay for Risperdal marketing practices. Last year, J&J agreed to pay $181 million to resolve claims by 36 states (see this), an Arkansas judge fined the health care giant $1 billion (look here) and J&J (JNJ) agreed to pay $158 million to settle a lawsuit brought by the Texas attorney general (back story). And two years ago, J&J was ordered by a South Carolina judge to pay $327 million for deceptive marketing, which he called detestable (see here).
In 2006, the FDA approved risperidone for the treatment of irritability in children and adolescents with autism.[26] The FDA's decision was based in part on a study of autistic people with severe and enduring problems of violent meltdowns, aggression, and self-injury; risperidone is not recommended for autistic people with mild aggression and explosive behavior without an enduring pattern.[27]
The jury found the companies had downplayed multiple risks associated with risperidone (Risperdal). The judge held that nearly 240,000 violations of the state's Medicaid fraud law had been committed. Each violation carried a fine of $5,000. The companies were also fined $11 million for more than 4,500 violations of the state’s deceptive practices laws.
MrOmega wrote:What do the clinical trials say on the matter?
Cate68 wrote:I didn't know that there was a lawsuit, but I am not surprised.
Users browsing this forum: niveone and 3 guests